Analysis of FcγRII gene polymorphisms in Wegener's granulomatosis

Experimental and Clinical Immunogenetics

Volumn 14, Issue 3, 1998, Pages 183-195

  Edberg, Jeffrey C ^a   Wainstein, Eduardo ^b   Wu, Jianming ^a   Csernok, Elena ^c   Sneller, Michael C ^d   Hoffman, Gary S ^e   Keystone, Edward C ^f   Gross, Wolfgang L ^c   Kimberly, Robert P ^a  

^a The University of Alabama at Birmingham   (United States)

^b HOSPITAL DEL SALVADOR   (Chile)

^c UNIVERSITY OF LÜBECK   (Germany)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

ANCA; Fc receptors; Monocyte macrophages; Mononuclear phagocytes; Neutrophils; Vasculitis

Indexed keywords

FC RECEPTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY; FC GAMMA RECEPTOR IIA; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN;

ANTIBODY TITER; ARTICLE; DEGRANULATION; DISEASE SEVERITY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL; RECEPTOR GENE; RESPIRATORY BURST; WEGENER GRANULOMATOSIS; ALLELE; GENETICS; IMMUNOLOGY;

ALLELES; ANTIGENS, CD; HUMANS; IMMUNOGLOBULIN G; POLYMORPHISM, GENETIC; RECEPTORS, IGG; WEGENER GRANULOMATOSIS;

EID: 0031283050     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Hulett MD, Hogarth PM: Molecular basis of Fc receptor function. Adv Immunol 1994;57:1-127.
2. Edberg JC, Salmon JE, Kimberly RP: Functional capacity of Fey receptor III (CD16) on human neutrophils. Immunol Res 1992;11:239-251.
3. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P: Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 1995;269:1435-1439.
4. Kimberly RP, Salmon JE, Edberg JC: Receptors for immunoglobulin G. Molecular diversity and implications for disease. Arthritis Rheum 1995;38:306-314.
5. Gosselin EJ, Wardwell K, Rigby WF, Guyre PM: Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/ macrophage colony-stimulating factor, IFN-γ, and IL-3. J Immunol 1993;151:1482-1490.
6. Hamada F, Aoki M, Akiyama T, Toyoshima K: Association of immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase Fgr in neutrophils. Proc Natl Acad Sci USA 1993;90:6305-6309.
7. Kiener PA, Rankin BM, Burkhardt AL, Schieven GL, Gilliland LK, Rowley RB, Bolen JB, Ledbetter JA: Cross-linking of Fey receptor I (FcγRI) and receptor II (FcγRII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase. J Biol Chem 1993;268: 24442-24448.
8. Choi OH, Kim JH, Kinet JP: Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor. Nature 1996; 380:634-636,.
9. Salmon JE, Edberg JC, Brogle NL, Kimberly RP: Allelic polymorphisms of human Fey receptor IIA and Fey receptor IIIB. Independent mechanisms for differences in hu-man phagocyte function. J Clin Invest 1992;89:1274-1281.
10. Parren PW, Warmerdam PA, Boeije LC, Arts J, Westerdaal NA, Vlug A, Capel PJ, Aarden LA, van de Winkel JG: On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 1992;90:1537-1546.
11. Sanders LA, van de Winkel JG, Rijkers GT, Voorhorst-Ogink MM, de Haas M, Capel PJ, Zegers BJ: Fcγ receptor lia (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 1994;170:854-861.
12. Fijen CA, Bredius RG, Kuijper EJ: Polymorphism of IgG Fc receptors in meningococcal disease (letter). Ann Intern Med 1993;119:636.
13. Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA: Fey receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994; 170:848-853.
14. Duits AJ, Bootsma H, Derksen RH, Spronk PE, Kater L, Kallenberg CG, Capel PJ, Westerdaal NA, Spierenburg GT, Gmelig-Meyling FH, van de Winkel JGJ: Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995;38:1832-1836.
15. Botto M, Theodoridis E, Thompson EM, Beynon, Briggs D, Isenberg DA, Walport MJ, Davies KA: FcγRIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease. Clin Exp Immunol 1996:104:264-268.
16. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, Ramsey-Goldman R, Peterson MG, Kimberly RP: FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996;97:1348-1354.
17. Bredius RG, Fijen CA, De Haas M, Kuijper EJ, Weening RS, Van de Winkel JG, Out TA: Role of neutrophil FcγRIIa (CD32) and FcγRIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 1994;83:624-630.
18. Kurosaki T, Ravetch JV: A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of FcγRIII. Nature 1989;342:805-807.
19. Bazil V, Strominger JL: Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. J Immunol 1994;152:1314-1322.
20. Tosi MF, Zakem H: Surface expression of Fcγ receptor III (CD16) on chemoattractant-stimulated neutrophils is determined by both surface shedding and translocation from intracellular storage compartments. J Clin Invest 1992,90:462-470.
21. Voice JK, Lachmann PJ: Interactions of defined soluble IgG immune complexes with Fc and complement receptors on human neutrophils (PMN). Proc Int Congr Immunol 1995;9:4626.
22. Edberg JC, Kimberly RP: Modulation of Fey and complement receptor function by te glycosyl-phosphatidylinositol-anchored form of FcγRIII. J Immunol 1994;152: 5826-5835.
23. Zhou MJ, Lublin DM, Link DC, Brown EJ: Distinct tyrosine kinase activation and Triton X-100 insolubility upon FcγRII or FcγRIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation of the respiratory burst. J Biol Chem 1995; 270:13553-13560.
24. Zhou MJ, Brown EJ: CR3 (Mac-1, αM β2, CD11b/CD18) and FcγRIII cooperate in generation of a neutrophil respiratory burst: requirement for FcγRIII and tyrosine phosphorylation. J Cell Biol 1994;125:1407-1416.
25. Salmon JE, Millard SS, Brogle NL, Kimberly RP: Fcγ receptor IIIb enhances Fcγ receptor IIa function in an oxidant-dependent and alleie-sensitive manner. J Clin Invest 1995;95:2877-2885.
26. Ravetch JV, Perussia B: Alternative membrane forms of FcγRIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 1989;170:481-497.
27. Huizinga TW, Kleijer M, Tetteroo PA, Roos D, von dem Borne AE: Biallelic neutrophil Na-antigen system is associated with a polymophism on the phospho-inositol-linked Fey receptor III (CD16). Blood 190;75:213-217.
28. Bux J, Stein EL, Bierling P, Fromont P, Clay M, Stroncek D, Santoso S: Characterization of a new alloantigen (SH) on the human neutrophil Fey receptor IIIb. Blood 1997;89: 1027-1034.
29. Salmon JE, Edberg JC, Kimberly RP: Fcγ receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest 1990;85:1287-1295.
30. Edberg JC, Redecha PB, Salmon JE, Kimberly RP: Human FcγRIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells. J Immunol 1989;143:1642-1649.
31. Zhou M, Todd RFd, van de Winkel JG, Petty HR: Cocapping of the leukoadhesion molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fey receptor III on human neutrophils. Possible role of lectin-like interactions. J Immunol 1993;150: 3030-3041.
32. Ernst LK, van de Winkel JG, Chiu IM, Anderson CL: Three genes for the human high affinity Fc receptor for IgG (FcγRI) encode four distinct transcription products. J Biol Chem 1992,267:15692-15700.
33. Porges AJ, Redecha PB, Doebele R, Pan LC, Salmon JE, Kimberly RP: Novel Fcγ receptor I family gene products in human mononuclear cells. J Clin Invest 1992;90:2102-2109.
34. Ernst LK, Duchemin AM, Anderson CL: Association of the high-affinity receptor for IgG (FcγRI) with the y subunit of the IgE receptor. Proc Natl Acad Sci USA 1993;90:6023-6027.
35. Scholl PR, Geha RS: Physical association between the high-affinity IgG receptor (FcγRI) and the y subunit of the high-affinity IgE receptor (FcεRIγ). Proc Natl Acad Sci USA 1993;90:8847-8850.
36. Wang AV, Scholl PR, Geha RS: Physical and functional association of the high affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn. J Exp Med 1994;180: 1165-1170.
37. Cassel DL, Keller MA, Surrey S, Schwartz E, Schreiber AD, Rappaport EF, McKenzie SE: Differential expression of FcγRIIA, FcγRIIB and FcγRIIC in hematopoietic cells: Analysis of transcripts. Mol Immunol 1993;30:451-460.
38. Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH: The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995;3:635-646.
39. Vance BA, Huizinga TW, Wardwell K, Guyre PM: Binding of monomeric human IgG defines an expression polymorphism of FcγRIII on large granular lymphocyte/natural killer cells. J Immunol 1993;151:6429-6439.
40. Edberg JC, Kimberly RP: Cell-type specific glycoforms of FcγRIIIa (CD16): Differential ligand binding. J Immunol 1997;159:3849-3857.
41. Wirthmueller U, Kurosaki T, Murakami MS, Ravetch JV: Signal transduction by FcγRIII (CD16) is mediated through the γ chain. J Exp Med 1992,175:1381-1390.
42. Kurosaki T, Gander I, Wirthmueller U, Ravetch JV: The β subunit of the FcεRI is associated with the FcγRIII on mast cells. J Exp Med 1992;175: 447-451.
43. de Haas M, Koene HR, Kleijer M, de Vries E, Simsek S, van Toi MJ, Roos D, von dem Borne AE: A triallelic Fcγ receptor type IIIA polymorphism influences the binding of human IgG by NK cell FcγRIIIa J Immunol 1996;156:3948-3955.
44. Koene HR, de Haas M, Roos D, von dem Borne AEGK: Soluble FcγRIII: Biological and clinical implications; in van de Winkel JGJ, Capel PJA (eds): Human Fc Receptors. Austin, Landes 1996, pp 181-193.
45. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, Salmon JE, Kimberly RP: A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997;100:1059-1070.
46. Hibbs ML, Tolvanen M, Carpen O: Membrane-proximal Ig-like domain of FcγRIII (CD16) contains residues critical for ligand binding. J Immunol 1994;152:4466-4474.
47. Hulett MD, Witort E, Brinkworth RI, McKenzie IF, Hogarth PM: Multiple regions of human FcγRII (CD32) contribute to the binding of IgG. J Biol Chem 1995;270:21188-21194.
48. Tamm A, Kister A, Nolte KU, Hessner JE, Schmidt RE: The IgG binding site of human FcγRIIIB receptor involves CC′ and FG loops of the membrane-proximal domain. J Biol Chem 1996;271:3659-3666.
49. Gross WL, Csernok E: Immuno-diagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheum 1995;7:11-19.
50. Chatham WW, Turkiewicz A, Blackburn WD, Jr. Determinants of neutrophil HOCl generation: Ligand-dependent responses and the role of surface adhesion. J Leuk Biol 1994;56:654-660.
51. Hundt M, Zielinska-Skowronek M, Schmidt RE: Fcγ receptor activation of neutrophils in cryoglobulin-induced leukocytoclastic vasculitis. Arthritis Rheum 1993;36:974-982.
52. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL: Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994;95: 244-250.
53. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-4119.
54. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CG: Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a FcγRII-dependent process. Clin Exp Immunol 1994;98: 270-278.
55. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP: Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcγRIIa. J Immunol 1994;153:1271-1280.
56. Keogan MT, Rifkin I, Ronda N, Lockwood CM, Brown DL: Anti-neutrophil cytoplasm antibodies (ANCA) increase neutrophil adhesion to cultured human endothelium. Adv Exp Med Biol 1993;336: 115-119.
57. Mulder AH, Stegeman CA, Kallenberg CG: Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: A predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 1995;101:227-232.
58. Brouwer E, Huitema MG, Mulder AH, Heeringa P, van Goor H, Tervaert JW, Weening JJ, Kallenberg CG: Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 1994;45:1120-1131.
59. Jayne DR, Weetman AP, Lockwood CM: IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991;84:476-481.
60. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-314.
61. Molad Y, Buyon J, Anderson DC, Abramson SB, Cronstein BN: Intravascular neutrophil activation in systemic lupus erythematosus (SLE): Dissociation between increased expression of CD11b/CD18 and diminished expression of L-Selectin on neutrophils from patients with active SLE. Clin Immunol Immunopath 1994;71:281-286.
62. Muller-Kobold AC, Mesander G, Kallenberg GGM, Cohen JW. Circulating leukocytes of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis have increased expression of activation markers, but no increased expression of adhesion molecules (abstract). Sarcoidosis 1996;13:263.
63. Kocher M, Siegel ME, Edberg JC, Kimberly RP: Crosslinking of FcγRIIa and FcγRIIIb induces different proadhesive phenotypes on human neutrophils. J Immunol 1997;159:3940-3948.
64. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-1107.
65. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG; Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
66. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL: Influence of disease manifestation and anti-neutrophil cytoplasmic antibody titer on the response to pulse cyclo-phosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:919-924.
67. De Remee RA, McDonald TJ, Harrison EG Jr, Coles DT: Wegener's granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc 1976;51:777-781.
68. Warmerdam PA, Nabben NM, van de Graaf SA, van de Winkel JG, Capel PJ: The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal crossover event. J Biol Chem 1993;268: 7346-7349.
69. Tse WY, Quibell K, Kumarate DS, Jefferis R, Bacon P, Savage COS, Adu D: Neutrophil FcγRIIa receptor polymorphisms in ANCA-positive vasculitis. Sarcoidosis Vasculitis Diffuse Lung Dis 1996;13:269.
70. Pierpot HA, Heeringa P, Cohen TJW, Stegeman CA, Duits A, Kallenberg CGM: FcγRIIa polymorphism and neutrophil activation by anti-neutrophil cytoplasmic antibodies (ANCA). Clin Exp Immunol 1995;101(suppl I):35.
71. Segelmark M, Wieslander J: ANCA and IgG subclasses. Adv Exp Med Biol 1993;336:71-75.
72. Wainstein E, Edberg J, Csernok E, Sneller M, Hoffman G, Keystone E, Gross W, Salmon J, Kimberly R: FcγRIIIB alleles predict renal dysfunction in Wegener's granulomatosis. Arthritis Rheum 1996;39:S210.
73. Osborne JM, Chacko GW, Brandt JT, Anderson CL: Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes. J Immunol Methods 1994;173:207-217.
74. Noms CF, Surrey S, Bunin GR, Schwartz E, Buchanan GR, McKenzie SE: Relationship between Fc receptor IIA polymorphism and infection in children with sickle cell disease. J Pediatr 1996;128:813-819.